EpiVax
EpiVax, based in Providence, RI, is a leader in immunogenicity assessment and sequence optimization for biologic therapeutics and vaccines. With over 26 years of experience and a portfolio that includes partnerships with 17 of the top 20 pharmaceutical companies, EpiVax employs innovative in silico and in vitro techniques to ensure the effectiveness and safety of its clients' products.
The company has analyzed 12 million sequences and boasts a strong collaborative network, including 500 industry, agency, and academic partners. Renowned for their detailed scientific reporting and responsive communication, EpiVax is dedicated to providing comprehensive insights that support product development and regulatory success.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.